The political theater surrounding the nomination of high-profile reformists to lead the Department of Health and Human Services (HHS) has once again ignited a fierce debate over the future of federal health regulation. With promises to fundamentally overhaul the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National…

The intersection of generative artificial intelligence and political messaging has taken a distinctively clinical turn, raising significant concerns among healthcare communication professionals and bioethicists. A recently circulated deepfake video, which portrays a prominent political figure as a uniformed physician diagnosing public figures with a fictional psychological condition and prescribing a mock “treatment plan,” highlights a…

VERAXA Biotech AG (Nasdaq: VRXA) has officially marked a pivotal transition in its oncology pipeline, announcing the initiation of cell line development for its flagship BiTAC T-cell engager program. This critical milestone, achieved in collaboration with bioengineering pioneer ATUM, represents a significant leap forward from early-stage candidate discovery toward robust, scalable clinical manufacturing. By leveraging…

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!